|
Valiant Laboratories Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
471.76 Cr.
|
P/BV
|
1.49
|
Book Value (Rs.)
|
58.14
|
|
52 Week High/Low (Rs.)
|
119/75
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
19/07/2025
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 75.60 | 151.47 | 242.64 |
| Total Income From Operations | 75.60 | 151.47 | 242.64 |
| | | | |
| EXPENDITURE | | | |
| Consumption of Raw Materials | 65.63 | 138.70 | 202.45 |
| Increase/Decrease in Stocks | 2.68 | -0.45 | 0.10 |
| Employees Cost | 3.26 | 3.05 | 2.92 |
| Depreciation | 1.57 | 1.45 | 1.12 |
| Other Expenses | 12.53 | 14.04 | 11.60 |
| Total Expenses | 85.68 | 156.79 | 218.19 |
| | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -10.08 | -5.32 | 24.45 |
| Other Income | 7.75 | 7.18 | 2.13 |
| P/L Before Interest, Excpt. Items & Tax | -2.33 | 1.85 | 26.58 |
| Interest | 0.12 | 0.06 | 0.23 |
| P/L Before Exceptional Items & Tax | -2.45 | 1.80 | 26.36 |
| P/L Before Tax | -2.45 | 1.80 | 26.36 |
| Tax | 0.45 | 0.24 | 6.94 |
| P/L After Tax from Ordinary Activities | -2.90 | 1.56 | 19.42 |
| Net Profit/Loss For the Period | -2.90 | 1.56 | 19.42 |
| Net P/L After Minority Interest & Share Of Associates | -2.90 | 1.56 | 19.42 |
| | | | |
| Equity Share Capital | 43.45 | 43.45 | 16.28 |
| EPS Before Extra Ordinary * | | | |
| Basic EPS (Rs.) | -0.66 | 0.40 | 11.93 |
| Diluted EPS (Rs.) | (0.67) | 0.40 | 11.93 |
| EPS After Extra Ordinary * | | | |
| Basic EPS (Rs.) | -0.66 | 0.40 | 11.93 |
| Diluted EPS (Rs.) | (0.67) | 0.40 | 11.93 |
| | | | |
| PBITOE Margin (%) | -13.33 | -3.51 | 10.07 |
| PBTE Margin (%) | -3.24 | 1.18 | 10.86 |
| PBT Margin (%) | -3.24 | 1.18 | 10.86 |
| PAT Margin (%) | -3.84 | 1.02 | 8.00 |
| PAT After MI And SOA Margin (%) | -3.84 | 1.02 | 8.00 |
